CellsHumansCancer VaccinesDendritic CellsMelanomaNanoparticles
Advances in mRNA-Based Melanoma Vaccines: A Narrative Review of Lipid Nanoparticle and Dendritic Cell Delivery Platforms.
Connor K Sisk, Laci M Turner, Shafkat Meraj, Nabiha Yusuf
Published: 202610.3390/cells15020099
Abstract
Melanoma remains one of the deadliest cutaneous malignancies worldwide, and despite advances in systemic therapy, recurrence and treatment resistance remain frequent challenges. Following the success of COVID-19 mRNA vaccines, mRNA-based cancer vacci…
Preview only. Read the full abstract at the source